Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA.

Pharmacol Rev. 2010 Dec;62(4):588-631. doi: 10.1124/pr.110.003004. Review.

2.

Endocannabinoids and Their Pharmacological Actions.

Pertwee RG.

Handb Exp Pharmacol. 2015;231:1-37. doi: 10.1007/978-3-319-20825-1_1. Review.

PMID:
26408156
3.
4.

The pharmacology of cannabinoid receptors and their ligands: an overview.

Pertwee RG.

Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. Review.

PMID:
16570099
5.

The therapeutic potential of novel cannabinoid receptors.

Kreitzer FR, Stella N.

Pharmacol Ther. 2009 May;122(2):83-96. doi: 10.1016/j.pharmthera.2009.01.005. Epub 2009 Feb 25. Review.

6.

WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.

Fakhfouri G, Ahmadiani A, Rahimian R, Grolla AA, Moradi F, Haeri A.

Neuropharmacology. 2012 Sep;63(4):653-66. doi: 10.1016/j.neuropharm.2012.05.013. Epub 2012 May 23.

PMID:
22634229
7.

Pharmacological actions of cannabinoids.

Pertwee RG.

Handb Exp Pharmacol. 2005;(168):1-51. Review.

PMID:
16596770
8.

Why do cannabinoid receptors have more than one endogenous ligand?

Di Marzo V, De Petrocellis L.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3216-28. doi: 10.1098/rstb.2011.0382. Review.

9.

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.

Pertwee RG.

Addict Biol. 2008 Jun;13(2):147-59. doi: 10.1111/j.1369-1600.2008.00108.x. Review.

PMID:
18482430
10.

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG.

Pharmacol Rev. 2002 Jun;54(2):161-202. Review.

11.

CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.

Mato S, Alberdi E, Ledent C, Watanabe M, Matute C.

Glia. 2009 Feb;57(3):295-306. doi: 10.1002/glia.20757.

PMID:
18814177
12.

Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.

Fan Y, Hooker BA, Garrison TR, El-Kouhen OF, Idler KB, Holley-Shanks RR, Meyer MD, Yao BB.

Eur J Pharmacol. 2011 Jun 1;659(2-3):161-8. doi: 10.1016/j.ejphar.2011.03.020. Epub 2011 Mar 31.

PMID:
21458448
13.

A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.

Chiba T, Ueno S, Obara Y, Nakahata N.

J Pharm Pharmacol. 2011 May;63(5):636-47. doi: 10.1111/j.2042-7158.2011.01250.x. Epub 2011 Mar 28.

PMID:
21492165
15.

An introduction to the endocannabinoid system: from the early to the latest concepts.

De Petrocellis L, Di Marzo V.

Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):1-15. doi: 10.1016/j.beem.2008.10.013. Review.

PMID:
19285257
16.

Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.

Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M.

Brain Res Mol Brain Res. 2004 Dec 6;132(1):87-92.

PMID:
15548432
17.
18.

The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.

Miller LK, Devi LA.

Pharmacol Rev. 2011 Sep;63(3):461-70. doi: 10.1124/pr.110.003491. Epub 2011 Jul 13. Review.

19.

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

Davis MP.

Expert Opin Investig Drugs. 2014 Aug;23(8):1123-40. doi: 10.1517/13543784.2014.918603. Epub 2014 May 16. Review.

PMID:
24836296
20.

The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.

Di Marzo V.

Pharmacol Res. 2009 Aug;60(2):77-84. doi: 10.1016/j.phrs.2009.02.010. Epub 2009 Mar 4. Review.

PMID:
19559360

Supplemental Content

Support Center